Summary
Osteosynthesis Implants Market Research Report Information By Product (Screws and Plates, Wires and Pins, Intramedullary Rods and Nails, and Spinal Fixation Devices), By Material (Stainless Steel, Titanium and Titanium Alloys, Bioabsorbable Polymers, and Others), By Fracture Type (Hip Fracture, Knee Fracture, Spine Fracture, Shoulder Fracture, and Others), By End User (Hospitals, Orthopaedic Clinics, and Ambulatory Surgical Centers) and by Region (North America, Europe, Asia-Pacific, and Rest of the World) Forecast till 2032
Market Overview
The Osteosynthesis Implants Market is anticipated to experience a compound annual growth rate (CAGR) of 6.99% from USD 5.67 Billion in 2024 to USD 9.66 Billion by 2032.
The global osteosynthesis implant market is being driven by the increasing prevalence of fractures and the rising incidence of osteoporosis worldwide. Nevertheless, the global market is anticipated to be constrained by the complications associated with osteosynthesis implants. However, the market is expected to generate profitable opportunities because of the global elderly population, ongoing clinical trials, and the acceleration of technological advancements.
The management of fractures is significantly complicated by osteoporosis, which is defined by a reduction in bone density and an increase in fragility. Osteoporosis increases the likelihood of fractures, particularly in weight-bearing bones like the hip, spine, and wrist. Fractures in osteoporotic bones frequently pose distinctive obstacles as a result of compromised bone quality and diminished mechanical stability. Osteosynthesis implants are essential in the treatment of fractures in osteoporotic patients, as they facilitate fracture healing and provide mechanical support.
Market segment insights
The segmentation of global osteosynthesis implants by product, screws and plates, wires and pins, intramedullary rods and nails, and spinal fixation devices.
Stainless steel, titanium and titanium alloys, bioabsorbable polymers, and other materials comprise the market segmentation.
The market has been segmented according to the type of fracture, including hip fracture, knee fracture, spine fracture, shoulder fracture, and others.
Hospitals, orthopedic clinics, and ambulatory surgical centers comprise the Osteosynthesis Implants Market, which has been segmented by end user.
Regional Perspectives
In 2022, North America Osteosynthesis Implants held the largest market share at 39.76%. It is expected to grow at a compound annual growth rate (CAGR) of 6.33% over the forecast period to reach approximately USD 3.98 billion by 2032. Nevertheless, Europe is anticipated to experience the most significant compound annual growth rate (CAGR) of 7.35% during the forecast period.
The North American Osteosynthesis Implants market is expected to experience sustained growth, which is a promising development. The osteosynthesis implants market is characterized by a high incidence of trauma and sports injuries, a rise in the number of orthopedic interventions, and an exceptional healthcare infrastructure and facilities.
The European Osteosynthesis Implants market is currently experiencing significant growth, which is being driven by a combination of factors. These factors include the increasing prevalence of osteoporosis, the growing number of sports injuries, and the growing awareness of the benefits of surgical intervention among patients.
In 2022, the Asia-Pacific Osteosynthesis Implants market was valued at USD 0.99 billion and is anticipated to expand at a compound annual growth rate (CAGR) of 5.13% over the forecast period. Furthermore, the market's expansion is further bolstered by the rapid population growth and the expanding healthcare infrastructure in developing countries.
In 2022, the Rest of the World Osteosynthesis Implants market was valued at USD 0.71 billion and is anticipated to expand at a compound annual growth rate (CAGR) of 2.76% over the projection period. The Middle East, Africa, and Latin America comprise the remainder of the world.
Major Players
Medartis AG, Dieter Marquardt Medizintechnik GmbH, Lepu Medical Technology (Beijing)Co.,Ltd., Globus Medical, Inc., Zimmer Biomet, Arthrex, Inc., Precision Spine, Inc., Johnson & Johnson Services, Inc., CONMED Corporation., and Braun SE are among the key companies in the osteosynthesis implant market.
ページTOPに戻る
Table of Contents
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY ............................................................................................................... 17
2 MARKET INTRODUCTION ............................................................................................................ 19
2.1 DEFINITION .................................................................................................................................................................. 19
2.2 SCOPE OF THE STUDY .............................................................................................................................................. 19
2.3 RESEARCH OBJECTIVE ............................................................................................................................................ 19
2.4 MARKET STRUCTURE .............................................................................................................................................. 19
3 RESEARCH METHODOLOGY ...................................................................................................... 20
3.1 OVERVIEW .................................................................................................................................................................... 20
3.2 DATA FLOW .................................................................................................................................................................. 22
3.2.1 DATA MINING PROCESS ................................................................................................................................. 22
3.3 PURCHASED DATABASE: ......................................................................................................................................... 23
3.4 SECONDARY SOURCES: ............................................................................................................................................ 24
3.4.1 SECONDARY RESEARCH DATA FLOW: ............................................................................................................. 25
3.5 PRIMARY RESEARCH: ............................................................................................................................................... 26
3.5.1 PRIMARY RESEARCH DATA FLOW: ................................................................................................................. 27
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED ......................................................................... 28
3.6 APPROACHES FOR MARKET SIZE ESTIMATION: ........................................................................................... 29
3.6.1 REVENUE ANALYSIS APPROACH ..................................................................................................................... 29
3.7 DATA FORECASTING................................................................................................................................................. 30
3.7.1 DATA FORECASTING TECHNIQUE .................................................................................................................... 30
3.8 DATA MODELLING ..................................................................................................................................................... 31
3.8.1 MICROECONOMIC FACTOR ANALYSIS: ............................................................................................................ 31
3.8.2 DATA MODELLING: ......................................................................................................................................... 32
3.9 TEAMS AND ANALYST CONTRIBUTION ........................................................................................................... 34
4 MARKET DYNAMICS .................................................................................................................... 36
4.1 INTRODUCTION ........................................................................................................................................................... 36
4.2 DRIVERS ......................................................................................................................................................................... 37
4.2.1 RISING INCIDENCES OF OSTEOPOROSIS ACROSS THE GLOBE .......................................................................... 37
4.2.2 INCREASING INCIDENCE OF FRACTURES ......................................................................................................... 38
4.3 RESTRAINTS ................................................................................................................................................................ 39
4.3.1 COMPLICATIONS ASSOCIATED WITH OSTEOSYNTHESIS IMPLANTS ................................................................ 39
4.4 OPPORTUNITY ............................................................................................................................................................. 40
4.4.1 GROWING TECHNOLOGICAL ADVANCMENTS AND ONGOING CLINICAL TRIALS ................................................ 40
4.4.2 INCREASING ELDERLY POPULATION, WORLDWIDE ........................................................................................... 40
5 MARKET FACTOR ANALYSIS ...................................................................................................... 41
5.1 PORTER'S FIVE FORCES MODEL ........................................................................................................................... 41
5.1.1 THREAT OF NEW ENTRANTS ........................................................................................................................... 41
5.1.2 BARGAINING POWER OF SUPPLIERS ............................................................................................................... 42
5.1.3 THREAT OF SUBSTITUTES .............................................................................................................................. 42
5.1.4 BARGAINING POWER OF BUYERS .................................................................................................................... 42
5.1.5 INTENSITY OF RIVALRY .................................................................................................................................. 42
5.2 IMPACT OF COVID-19 ON THE GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET ............................. 43
6 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, BY PRODUCT ............................................ 45
6.1 OVERVIEW .................................................................................................................................................................... 45
6.2 SCREWS AND PLATES .............................................................................................................................................. 47
6.3 WIRES AND PINS ........................................................................................................................................................ 48
6.4 INTRAMEDULLARY RODS AND NAILS ............................................................................................................... 48
6.5 SPINAL FIXATION DEVICES ................................................................................................................................... 49
7 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, BY MATERIAL ........................................... 50
7.1 OVERVIEW .................................................................................................................................................................... 50
7.2 STAINLESS STEEL ..................................................................................................................................................... 52
7.3 TITANIUM AND TITANIUM ALLOYS .................................................................................................................. 53
7.4 BIOABSORBABLE POLYMERS................................................................................................................................. 53
7.5 OTHERS .......................................................................................................................................................................... 54
8 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, BY FRACTURE TYPE ................................ 55
8.1 OVERVIEW .................................................................................................................................................................... 55
8.2 HIP FRACTURE ............................................................................................................................................................ 57
8.3 KNEE FRACTURE ....................................................................................................................................................... 58
8.4 SPINE FRACTURE ....................................................................................................................................................... 58
8.5 SHOULDER FRACTURE ............................................................................................................................................. 59
8.6 OTHERS .......................................................................................................................................................................... 59
9 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, BY END USER ........................................... 60
9.1 OVERVIEW .................................................................................................................................................................... 60
9.2 HOSPITALS ................................................................................................................................................................... 61
9.3 ORTHOPAEDIC CLINICS ............................................................................................................................................ 62
9.4 AMBULATORY SURGICAL CENTERS ................................................................................................................... 62
10 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, BY REGION ............................................... 63
10.1 OVERVIEW .................................................................................................................................................................... 63
10.2 NORTH AMERICA ....................................................................................................................................................... 65
10.2.1 US.................................................................................................................................................................. 68
10.2.2 CANADA ........................................................................................................................................................ 70
10.3 EUROPE .......................................................................................................................................................................... 72
10.3.1 GERMANY ...................................................................................................................................................... 75
10.3.2 FRANCE ......................................................................................................................................................... 76
10.3.3 UK ................................................................................................................................................................. 78
10.3.4 ITALY ............................................................................................................................................................. 79
10.3.5 SPAIN ............................................................................................................................................................ 80
10.3.6 REST OF EUROPE ............................................................................................................................................ 82
10.4 ASIA-PACIFIC ............................................................................................................................................................... 84
10.4.1 CHINA ............................................................................................................................................................ 87
10.4.2 INDIA ............................................................................................................................................................. 88
10.4.3 JAPAN ........................................................................................................................................................... 90
10.4.4 SOUTH KOREA ................................................................................................................................................ 91
10.4.5 AUSTRALIA .................................................................................................................................................... 92
10.4.6 REST OF ASIA-PACIFIC ................................................................................................................................... 94
10.5 REST OF THE WORLD ................................................................................................................................................ 96
10.5.1 MIDDLE EAST & AFRICA .................................................................................................................................. 99
10.5.2 LATIN AMERICA ............................................................................................................................................. 100
11 COMPETITIVE LANDSCAPE ........................................................................................................ 103
11.1 INTRODUCTION ........................................................................................................................................................... 103
11.2 MARKET SHARE ANALYSIS, 2022 ....................................................................................................................... 103
11.3 COMPETITOR DASHBOARD..................................................................................................................................... 104
11.4 PUBLIC PLAYERS STOCK SUMMARY ................................................................................................................. 105
11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL .............................................................................. 105
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES ............................................................................................ 106
11.6.1 PRODUCT LAUNCH/ PRODUCT APPROVAL ...................................................................................................... 106
11.6.2 MERGER ......................................................................................................................................................... 107
11.6.3 ACQUISITION ................................................................................................................................................. 107
12 COMPANY PROFILES .................................................................................................................. 108
12.1 B. BRAUN SE ................................................................................................................................................................. 108
12.1.1 COMPANY OVERVIEW ..................................................................................................................................... 108
12.1.2 FINANCIAL OVERVIEW .................................................................................................................................... 109
12.1.3 PRODUCTS OFFERED ...................................................................................................................................... 109
12.1.4 KEY DEVELOPMENTS ...................................................................................................................................... 110
12.1.5 SWOT ANALYSIS ............................................................................................................................................ 111
12.1.6 KEY STRATEGIES ............................................................................................................................................ 111
12.2 JOHNSON & JOHNSON SERVICES, INC. ............................................................................................................... 112
12.2.1 COMPANY OVERVIEW ..................................................................................................................................... 112
12.2.2 FINANCIAL OVERVIEW .................................................................................................................................... 113
12.2.3 PRODUCTS OFFERED ...................................................................................................................................... 113
12.2.4 KEY DEVELOPMENTS ...................................................................................................................................... 115
12.2.5 SWOT ANALYSIS ............................................................................................................................................ 115
12.2.6 KEY STRATEGIES ............................................................................................................................................ 116
12.3 CONMED CORPORATION .......................................................................................................................................... 117
12.3.1 COMPANY OVERVIEW ..................................................................................................................................... 117
12.3.2 FINANCIAL OVERVIEW .................................................................................................................................... 118
12.3.3 PRODUCTS OFFERED ...................................................................................................................................... 118
12.3.4 KEY DEVELOPMENTS ...................................................................................................................................... 119
12.3.5 KEY STRATEGIES ............................................................................................................................................ 120
12.4 GLOBUS MEDICAL, INC. ............................................................................................................................................ 121
12.4.1 COMPANY OVERVIEW ..................................................................................................................................... 121
12.4.2 FINANCIAL OVERVIEW .................................................................................................................................... 122
12.4.3 PRODUCTS OFFERED ...................................................................................................................................... 122
12.4.4 KEY DEVELOPMENTS ...................................................................................................................................... 124
12.4.5 SWOT ANALYSIS ............................................................................................................................................ 125
12.4.6 KEY STRATEGIES ............................................................................................................................................ 125
12.5 ZIMMER BIOMET ........................................................................................................................................................ 126
12.5.1 COMPANY OVERVIEW ..................................................................................................................................... 126
12.5.2 FINANCIAL OVERVIEW .................................................................................................................................... 127
12.5.3 PRODUCTS OFFERED ...................................................................................................................................... 127
12.5.4 KEY DEVELOPMENTS ...................................................................................................................................... 128
12.5.5 SWOT ANALYSIS ............................................................................................................................................ 129
12.5.6 KEY STRATEGIES ............................................................................................................................................ 129
12.6 ARTHREX, INC. ............................................................................................................................................................ 130
12.6.1 COMPANY OVERVIEW ..................................................................................................................................... 130
12.6.2 FINANCIAL OVERVIEW .................................................................................................................................... 130
12.6.3 PRODUCTS OFFERED ...................................................................................................................................... 130
12.6.4 KEY DEVELOPMENTS ...................................................................................................................................... 131
12.6.5 KEY STRATEGIES ............................................................................................................................................ 131
12.7 PRECISION SPINE INC. .............................................................................................................................................. 132
12.7.1 COMPANY OVERVIEW ..................................................................................................................................... 132
12.7.2 FINANCIAL OVERVIEW .................................................................................................................................... 132
12.7.3 PRODUCTS OFFERED ...................................................................................................................................... 132
12.7.4 KEY DEVELOPMENTS ...................................................................................................................................... 133
12.7.5 KEY STRATEGIES ............................................................................................................................................ 133
12.8 MEDARTIS AG .............................................................................................................................................................. 134
12.8.1 COMPANY OVERVIEW ..................................................................................................................................... 134
12.8.2 FINANCIAL OVERVIEW .................................................................................................................................... 135
12.8.3 PRODUCTS OFFERED ...................................................................................................................................... 135
12.8.4 KEY DEVELOPMENTS ...................................................................................................................................... 138
12.8.5 KEY STRATEGIES ............................................................................................................................................ 138
12.9 DIETER MARQUARDT MEDIZINTECHNIK GMBH ........................................................................................... 139
12.9.1 COMPANY OVERVIEW ..................................................................................................................................... 139
12.9.2 FINANCIAL OVERVIEW .................................................................................................................................... 139
12.9.3 PRODUCTS OFFERED ...................................................................................................................................... 139
12.9.4 KEY DEVELOPMENTS ...................................................................................................................................... 141
12.9.5 KEY STRATEGIES ............................................................................................................................................ 141
12.10 LEPU MEDICAL TECHNOLOGY(BEIJING)CO., LTD. .......................................................................................... 142
12.10.1 COMPANY OVERVIEW ..................................................................................................................................... 142
12.10.2 FINANCIAL OVERVIEW .................................................................................................................................... 143
12.10.3 PRODUCTS OFFERED ...................................................................................................................................... 143
12.10.4 KEY DEVELOPMENTS ...................................................................................................................................... 146
12.10.5 SWOT ANALYSIS ............................................................................................................................................ 146
12.10.6 KEY STRATEGIES ............................................................................................................................................ 146
13 DATA CITATIONS ......................................................................................................................... 148
